Anti-CD20 antibodies are used to treat conditions such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. They also have other uses, such as treating certain autoimmune disorders. These medications work by targeting CD20 proteins found on the surface of B cells, which are a type of white blood cell involved in these conditions. By binding to the CD20 protein, these antibodies help destroy the B cells. Anti-CD20 antibodies are available in injectable forms. Examples include Rituxan (rituximab), Gazvya (obinutuzumab), and more.
